Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese

被引:37
作者
Wang, Fen
Jia, Jianping [1 ]
机构
[1] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing 100053, Peoples R China
[2] Minist Educ, Neurodegenerat Lab, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; cholesterol; 24-hydroxylase; ATP-binding cassette transporter A1; polymorphism;
D O I
10.1016/j.brainres.2007.02.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have demonstrated that cholesterol metabolism might play an important role in Alzheimer's disease (AD). Cholesterol 24-hydroxylase (CYP46) and ATP-binding cassette transporter A1 (ABCA1) have both been proposed to be involved in cholesterol metabolism in the brain. The purpose of this case-control study was to determine whether single nucleotide polymorphisms (SNPs) A -> G in the intron 2 of CYP46 gene and G -> A (R219K) in the exon 7 of ABCA1 gene are associated with sporadic AD in the Chinese Han population. Genotypes were determined by PCR-restriction fragment length polymorphism (PCR-RFLP) in 168 sporadic AD patients and 215 controls. There was no significant difference in the genotype or allele frequencies for CYP46 gene between AD patients and controls. However, we found an obvious association between the polymorphism of ABCA1 gene and AD (chi(2) =8.230, P=0.016). The risk for AD was significantly decreased in K allele (RK+KK genotypes) (adjusted OR=0.57, 95% CI=0.36-0.91, P=0.019) or KK homozygote carriers (adjusted OR=0.40; 95% CI=0.21-0.77, P=0.006) compared with RR genotypes carriers. Our results do not support a genetic association between the intron 2 polymorphism of CYP46 gene and the risk of sporadic AD, but reveal that KK genotype or K allele of ABCA1 gene may have a protective effect for sporadic AD in Chinese. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 34 条
[1]   Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators [J].
Borroni, B ;
Archetti, S ;
Agosti, C ;
Akkawi, N ;
Brambilla, C ;
Caimi, L ;
Caltagirone, C ;
Di Luca, M ;
Padovani, A .
NEUROBIOLOGY OF AGING, 2004, 25 (06) :747-751
[2]   APOE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease [J].
Chalmers, KA ;
Culpan, D ;
Kehoe, PG ;
Wilcock, GK ;
Hughes, A ;
Love, S .
NEUROREPORT, 2004, 15 (01) :95-98
[3]  
Clee SM, 2001, CIRCULATION, V103, P1198
[4]   Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease [J].
Desai, P ;
DeKosky, ST ;
Kamboh, MI .
NEUROSCIENCE LETTERS, 2002, 328 (01) :9-12
[5]   Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo [J].
Fassbender, K ;
Simons, M ;
Bergmann, C ;
Stroick, M ;
Lütjohann, D ;
Keller, P ;
Runz, H ;
Kühl, S ;
Bertsch, T ;
von Bergmannn, K ;
Hennerici, M ;
Beyreuther, K ;
Hartmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5856-5861
[6]   CYP46: A risk factor for Alzheimer's disease or a coincidence? [J].
Golanska, E ;
Hulas-Bigoszewska, K ;
Wojcik, I ;
Rieske, P ;
Styczynska, M ;
Peplonska, B ;
Pfeffer, A ;
Luczywek, E ;
Wasiak, B ;
Gabryelewicz, T ;
Religa, D ;
Chodakowska-Zebrowska, M ;
Barcikowska, M ;
Sobow, T ;
Liberski, PP .
NEUROSCIENCE LETTERS, 2005, 383 (1-2) :105-108
[7]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[8]   Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease [J].
Ingelsson, M ;
Jesneck, J ;
Irizarry, MC ;
Hyman, BT ;
Rebeck, GW .
NEUROSCIENCE LETTERS, 2004, 367 (02) :228-231
[9]   Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population [J].
Kabbara, A ;
Payet, N ;
Cottel, D ;
Frigard, B ;
Amouyel, P ;
Lambert, JC .
NEUROSCIENCE LETTERS, 2004, 363 (02) :139-143
[10]   Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism [J].
Katzov, H ;
Chalmers, K ;
Palmgren, J ;
Andreasen, N ;
Johansson, B ;
Cairns, NJ ;
Gatz, M ;
Wilcock, GK ;
Love, S ;
Pedersen, NL ;
Brookes, AJ ;
Blennow, K ;
Kehoe, PG ;
Prince, JA .
HUMAN MUTATION, 2004, 23 (04) :358-367